A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Iradimed Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 11,210 shares of IRMD stock, worth $945,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,210
Holding current value
$945,563
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$56.19 - $74.27 $629,889 - $832,566
11,210 New
11,210 $797,000
Q2 2023

Aug 14, 2023

BUY
$38.88 - $50.61 $19,517 - $25,406
502 New
502 $23,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $1.06B
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.